Back to Startup Insights
AOBiome Therapeutics
Develops therapies using Ammonia Oxidizing Bacteria (AOB) to treat inflammatory skin conditions like eczema and acne.
Headquarters
United States
Year Founded
2022
Founders
Not specified
Country
United States
Financial Information
Funding Stage
Growth Stage
Recent Funding
-
Funding By
Venture Investors
Core Technology
Ammonia Oxidizing Bacteria (AOB)
Product Type
Drug
Pipeline Stage (Very Important)
Clinical
Regulatory Status
- IND Filed: Yes
- FDA/EMA Status: Under Review
- Clinical Trial Registration: In Progress
- Patents / IP Status: Filed
Partnerships
Pharma Collaborations
Multiple
Academic / Hospital Tie-ups
US Research Institutions
CRO/CDMO Partnerships
In Progress
Market & Differentiation
Novel AOB-based therapy platform